Filter
4906
Filtered Results: 4906
Text search:
national
HIV
guidelines
Featured
Recommendations
460
New Publications
1467
Language
Document type
No document type
3197
Guidelines
624
Studies & Reports
544
Manuals
209
Strategic & Response Plan
158
Training Material
69
Fact sheets
55
Situation Updates
25
Infographics
11
Resource Platforms
8
Brochures
4
App
1
Online Courses
1
Countries / Regions
India
249
Kenya
195
South Africa
158
Uganda
128
Ethiopia
118
Malawi
116
Tanzania
115
Nigeria
113
Zambia
109
Global
107
Nepal
104
Sierra Leone
81
Rwanda
77
Liberia
75
Western and Central Europe
72
Ghana
69
Namibia
67
Bangladesh
63
Myanmar / Burma
59
Africa
56
Indonesia
56
Lesotho
50
Zimbabwe
48
Ukraine
47
Eastern Europe
46
Latin America and the Carribbean
45
Mozambique
44
Senegal
43
Philippines
41
Cambodia
37
Congo, Democratic Republic of
35
Brazil
33
Asia
32
Botswana
32
Argentina
30
Haiti
27
Colombia
26
Paraguay
26
Burkina Faso
24
Russia
24
Eswatini/ Swaziland
22
South–East Asia Region
20
Venezuela
19
South Sudan
19
Peru
18
Benin
16
Syria
16
East and Southern Africa
15
El Salvador
13
Cameroon
13
Germany
13
Guinea
11
Pakistan
11
Chile
10
Albania
10
West and Central Africa
10
Eastern Europe and Central Asia
10
Bolivia
10
Vietnam
10
Central African Republic
10
Georgia
9
Middle East and North Africa
8
Sudan
8
Madagascar
8
Tajikistan
7
Thailand
7
Southern Africa
7
Somalia
7
Ecuador
7
Jordan
6
Lebanon
6
Yemen
5
Angola
5
North Macedonia
4
Iran
4
Laos
4
Afghanistan
4
Burundi
4
Portugal
4
Papua New Guinea
4
Mali
4
Timor Leste/ East Timor
3
Mexico
3
Estonia
3
Armenia
3
USA
3
Western Pacific Region
3
Moldova
3
Sri Lanka
3
Iraq
3
Turkey
2
Gambia
2
Kyrgyzstan
2
Uzbekistan
2
Morocco
2
Qatar
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
Turkmenistan
2
Jamaica
2
Japan
2
United Kingdom
2
Spain
2
Egypt
2
Romania
2
Greece
2
Honduras
2
Bhutan
2
North Korea
1
Switzerland
1
Serbia
1
China
1
Kazakhstan
1
Canada
1
Singapore
1
Niger
1
Bulgaria
1
Dominican Republic
1
Croatia
1
North America
1
Gabon
1
Uruguay
1
Belgium
1
France
1
Mauritius
1
Tunisia
1
Norway
1
Azerbaijan
1
Belarus
1
Israel
1
Bosnia and Herzegovina
1
Côte d’Ivoire / Ivory Coast
1
Djibouti
1
Palestine
1
Poland
1
Libya
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2303
Clinical Guidelines
418
Women & Child Health
295
Public Health
185
Key Resources
147
Capacity Building
102
Pharmacy & Technologies
48
Annual Report MEDBOX
1
Toolboxes
HIV
735
TB
575
COVID-19
202
Mental Health
182
Caregiver
138
AMR
135
Pharmacy
86
Disability
84
Conflict
72
Rapid Response
69
Ebola
64
Refugee
61
NTDs
60
NCDs
48
Planetary Health
39
Global Health Education
36
Natural Hazards
25
Polio
24
Cholera
22
Health Financing Toolbox
19
Zika
19
Social Ethics
7
Specific Hazards
3
Developmental disabilities are common. Yet, children with developmental disabilities have been neglected in health systems planning and policy provisions for health and continue to experience stigmatization, institutionalization, barriers to access health care and inequalities in health and educatio...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
he global architecture for providing development assistance for health (DAH)
has become increasing complex in the last decade, with many new funding agencies entering the health sector.
This study presents a detailed picture of European Union (EU) and EU member state originating DAH
between 2006 ...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the world. Their drivers are social, environmental, commercial and geneti...
Mpox continues to affect people around the world. A new framework released today by WHO will guide health authorities, communities and other stakeholders in preventing and controlling mpox outbreaks, eliminating human-to-human transmission of the disease, and reducing spillover of the virus from ani...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory diseases – along with mental health, cause nearly three quarters of deaths in the world. Their drivers are social, environmental, commercial and geneti...
Mpox is a zoonotic disease caused by a double-stranded DNA virus that belongs to the Orthopoxvirus genus of the Poxviridae family. The disease presents with symptoms similar to smallpox but with a lesser severity. It was first discovered in 1958 when two outbreaks of a poxlike disease occurred in co...
Childhood Respiratory Diseases & the Environment learning objectives
•To understand how the respiratory tract is affected by the environment
•To describe respiratory diseases linked to the environment
•To list one population-level intervention and one personal-level intervention for d...
Toolkit regarding Zika Virus
This report on global leishmaniasis surveillance follows those published in 2016–2023.2–6 Six indicators of leishmaniasis are publicly available from the Global Health Observatory (GHO).7 In addition to the GHO, country profiles with up to 30 indicators are published, with detailed data received...
An estimated 1.3 billion people globally experience significant disability. This figure has grown over the last decade and will continue to rise due to demographic and epidemiological changes. In 2022, the World Health Organization launched the Global report on health equity for persons with disabil...
Strategical plan
